Acutus Medical announced receipt of a CE Mark issued under the European Union, or EU, Medical Device Regulations, or MDR, for its AcQMap 3D Imaging and Mapping Catheter, the world’s only integrated high-resolution ultrasound imaging and non-contact mapping catheter.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AFIB:
- Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter
- Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Acutus Medical Reports Third Quarter 2022 Financial Results
- Acutus Medical to Announce Third Quarter 2022 Financial Results
- Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter & System
